Carlsbad, CA, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing precision therapies for ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

BridgeBio Pharma, Inc.'s Attruby (Acoramidis) delivers early, durable reductions in cumulative cardiovascular events. Learn more on BBIO stock here.

UPPSALA, SE / ACCESS Newswire / November 11, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), a leader in solutions for personalized anesthesia, today announced that Philip Siberg, CEO of Senzime, will be pres ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell ...

Elation Health, the technology company powering innovation in primary care, today announced its expansion into pediatrics as part of its continued evolution into an AI-native platform, delivering ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsJonae Barnes - Senior Vice President of ...

The CBSE has announced that the Class XII Biology examination will be held on March 27, 2026, providing students a clear timeline for structured preparation. Covering topics from cell biology to ...

CBSE Class 12th Biology exam 2025: The Central Board of Secondary Education (CBSE) has officially announced that the Class XII Biology examination will be conducted on March 27, 2026. The declaration ...